NCT00492648View on ClinicalTrials.gov

Month 30 & 42 Extension Studies of CRD-004 Primary Study

PHASE2CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

June 25, 2007

Primary Completion Date

June 23, 2008

Study Completion Date

June 23, 2008

Conditions

Herpes Zoster

Interventions

PROCEDURE

Blood sampling for assay of persistence of immunogenicity

Two blood samples: 30 and 42 months after first vaccination

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY